awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36603168-52E3725E-CF0A-4C35-B7A9-0CA214AB6B22
Q36603168-52E3725E-CF0A-4C35-B7A9-0CA214AB6B22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603168-52E3725E-CF0A-4C35-B7A9-0CA214AB6B22
One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.
P2860
Q36603168-52E3725E-CF0A-4C35-B7A9-0CA214AB6B22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603168-52E3725E-CF0A-4C35-B7A9-0CA214AB6B22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04a8d1638daf0a5a325d59745c82521e1906eced
P2860
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels